( Rhone Poulenc Pharma Inc ) said plan spend 29 mln dlrs next five year research development Canada .
It said investment depends upon passage federal government bill proposes greater protection holder drug patent .
The company said spend 7.9 mln dlrs upgrade Montreal operation .
It said new patent law would give drug company reasonable protection generic drug copying new compound .
Reuter & # 3 ; 